Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Goodwill: 2022-2024

Historic Goodwill for Collegium Pharmaceutical (COLL) over the last 3 years, with Dec 2024 value amounting to $162.3 million.

  • Collegium Pharmaceutical's Goodwill fell 0.02% to $145.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $145.9 million, marking a year-over-year decrease of 0.02%. This contributed to the annual value of $162.3 million for FY2024, which is 21.27% up from last year.
  • According to the latest figures from FY2024, Collegium Pharmaceutical's Goodwill is $162.3 million, which was up 21.27% from $133.9 million recorded in FY2023.
  • Collegium Pharmaceutical's Goodwill's 5-year high stood at $162.3 million during FY2024, with a 5-year trough of $133.7 million in FY2022.
  • Its 3-year average for Goodwill is $143.3 million, with a median of $133.9 million in 2023.
  • Data for Collegium Pharmaceutical's Goodwill shows a peak YoY grew of 21.27% (in 2024) over the last 5 years.
  • Over the past 3 years, Collegium Pharmaceutical's Goodwill (Yearly) stood at $133.7 million in 2022, then grew by 0.12% to $133.9 million in 2023, then grew by 21.27% to $162.3 million in 2024.